Aehr Test Systems develops, manufactures and sells systems which are designed to reduce the cost of testing and to perform reliability screening, and stress testing, burn-in or cycling, of homogeneous and heterogenous logic and memory integrated circuits (ICs), sensors and optical devices. These systems can be used to simultaneously perform parallel testing and burn-in of packaged ICs, singulated bare die or ICs still in wafer form. The company's products families include the ABTS? and FOX? systems, the WaferPak? cartridge and the DiePak? carrier. The company manufactures and markets full wafer contact test systems, test during burn-in systems, test fixtures and related accessories.

Aemetis is a renewable fuels and biochemicals holding company. Through its subsidiaries, the company focuses on the production of renewable fuels and chemicals that replace petroleum-based products through the conversion of first-generation ethanol and biodiesel plants into biorefineries. The company's reportable geographic segments include: North America, which includes its ethanol production facility in Keyes, CA and produces denatured fuel ethanol, wet distillers grains, distillers corn oil, and condensed distillers solubles; and India, which includes its biodiesel manufacturing plant in Hyderabad, India and has biodiesel and refined glycerin.

Alderon Resource is a development stage company and is engaged in the business of acquiring, exploring and evaluating mineral resource properties, and either joint venturing or developing these properties further or disposing of them when the evaluation is completed.

Aldeyra Therapeutics is a biotechnology company engaged in developing and commercializing medicines for patients with immune-mediated diseases. The company's primary product candidate, reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. The company has additional product candidates in development for proliferative vitreoretinopathy and other retinal diseases, autoimmune disease, and cancer. The company has discovered and are developing two additional reactive aldehyde species inhibitors, ADX-103 and ADX-629, for the treatment of retinal disease and autoimmune disease, respectively.

American Superconductor is a provider of megawatt-scale solutions for power grid and wind power. The company operates its business under two market-facing business units: Grid, which enables electric utilities and renewable energy project developers to connect, transmit and distribute power, and these services lead to sales of the company's grid interconnection solutions for wind farms and solar power plants, power quality systems and transmission and distribution cable systems; and Wind, which supplies power electronics and control systems, licenses its engineered wind turbine designs, and provides customer support services to wind turbine manufacturers.

Carrols Restaurant Group is a holding company. Through its subsidiaries, the company is engaged as a Burger King? franchisee. The company owns and operates Burger King restaurants located in Northeastern, Midwestern and Southeastern states. Burger King restaurants feature the flame-broiled Whopper? sandwich, as well as a variety of hamburgers, chicken and other specialty sandwiches, french fries, salads, breakfast items, snacks, soft drinks and other offerings.

Celcuity is a cellular analysis company that is discovering new cancer sub-types and commercializing diagnostic tests designed to improve the clinical outcomes of cancer patients treated with targeted therapies. The company's proprietary CELx diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the targeted therapy that treats it. This enables physicians to select therapeutic that matches and inhibits a patient's cellular dysfunction.

Celsius Holdings is engaged in the development, marketing, sale and distribution of functional calorie-burning fitness beverages under the Celsius? brand name. Celsius? burns calories by increasing a consumer's resting metabolism and provides energy. Celsius? uses ingredients and supplements such as green tea, ginger, calcium, chromium, B vitamins and vitamin C. The company also sells a powdered form of the active ingredients in its beverages in individual On-The-Go packets as well as several serving canisters. In addition, the company has a second line in its product portfolio, trainer's grade Celsius Heat?. Celsius Heat? is also a dietary supplement.

China Yuchai International is a holding company. Through its subsidiaries, Co. engages in the manufacture, assembly and sale of a wide variety of light-, medium- and heavy-duty engines for trucks, buses, passenger vehicles, construction equipment, and marine and agriculture applications in China. Co. also produces engines for diesel power generators. The engines produced by Co. range from diesel to natural gas and hybrid engines. Through its regional sales offices and authorized customer service centers, Co. distributes its engines directly to auto original equipment manufacturers and retailers and provides maintenance and retrofitting services throughout China.

Great Lakes Dredge & Dock is a provider of dredging services. The company provides dredging services in the East, West, and Gulf Coasts of the U.S. and worldwide. The company operates in one operating segment, which is also the company's sole reportable segment and reporting unit. Dredging generally involves the enhancement or preservation of navigability of waterways or the protection of shorelines through the removal or replenishment of soil, sand or rock. Domestically, the company's work generally is performed in coastal waterways and deep water ports. The U.S. dredging market consists of four primary types of work: capital, coastal protection, maintenance and rivers and lakes.

GSI Technology designs, develops and markets a range of memory products, including Very Fast static random access memory (SRAM), that are incorporated primarily in networking and telecommunications equipment, such as routers, switches, network infrastructure equipment, wireless base stations and network access equipment. The company sells these products to original equipment manufacturer, customers including Nokia. In addition, the company serves the ongoing needs of the military, industrial, test and measurement equipment, automotive and medical markets for SRAMs.

IDEAYA Biosciences is an oncology-focused precision medicine company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's product candidate in clinical development is IDE196, a protein kinase C inhibitor for genetically-defined cancers having GNAQ or GNA11 gene mutations.

inTEST is an independent designer, manufacturer and marketer of thermal management products and automated test equipment (ATE) interface solutions which are used by semiconductor manufacturers to perform development, qualifying and final testing of integrated circuits (ICs) and wafers, and for other electronic testing across a range of industries including the automotive, defense/aerospace, energy, industrial and telecommunications markets. The company also provides induction heating products for joining and forming metals in a variety of industrial markets, including automotive, aerospace, machinery, wire and fasteners, medical, semiconductor, food and beverage, and packaging.

Ionis Pharmaceuticals is engaged in discovering and developing RNA-targeted therapeutics. The company has two commercial medicines, SPINRAZA and TEGSEDI. SPINRAZA (nusinersen) injection for intrathecal use is a survival motor neuron-2, directed antisense oligonucleotide indicated for the treatment of spinal muscular atrophy in pediatric and adult patients. TEGSEDI (inotersen) injection is a Generation 2+ antisense medicine and an approved subcutaneous RNA-targeting medicine designed to treat people with polyneuropathy caused by hereditary transthyretin amyloidosis.

Neogen develops, manufactures, and markets a line of products for food and animal safety. The company's segments are: Food Safety, which is engaged in the development, production and marketing of diagnostic test kits and related products used by food producers and processors to detect harmful natural toxins, foodborne bacteria, allergens and levels of general sanitation; and Animal Safety, which is engaged in the development, production and marketing of products dedicated to animal safety, including a range of consumable products marketed to veterinarians and animal health product distributors, and provides genomic identification and related interpretive bioinformatic services.

NetApp is the data authority for the hybrid cloud. The company's product, services and solutions portfolio include: cloud data services, which include the NetApp Data Fabric, which manages, secures, and protects the data of its customers from on-premises to public to hybrid cloud; cloud infrastructure, which helps customers build cloud-architected data centers; storage systems and software, which enables customers to modernize their IT architectures with cloud-connected flash to free the resources necessary; and support services, which enable a portfolio of technical services including independent support services, support account managers, residency services, and managed services.

Omeros is a commercial-stage biopharmaceutical company committed to discovering, developing and commercializing small-molecule and protein therapeutics for large-market as well as orphan indications targeting inflammation, complement-mediated diseases, disorders of the central nervous system and immune-related diseases, including cancers. The company's drug product OMIDRIA? is marketed in the U.S. for use during cataract surgery or intraocular lens replacement. In its pipeline the company has clinical-stage development programs focused on: complement-associated thrombotic microangiopathies; complement-mediated glomerulonephropathies; and addictive and compulsive disorders.

ON Semiconductor is engaged in energy efficient electronics. The company is organized into three segments: Power Solutions Group, which provides a range of discrete, module and integrated semiconductor products; Analog Solutions Group, which designs and develops analog, mixed-signal, and advanced logic application specific integrated circuits and Application Specific Standard Product, and power solutions; and Image Sensor Group, which designs and develops complementary metal oxide semiconductor and charge-coupled device image sensors, as well as proximity sensors, image signal processors and actuator drivers for autofocus and image stabilization for automotive and industrial markets, among others.

Protagonist Therapeutics is a clinical-stage biopharmaceutical company with a proprietary technology platform that discovers and develops peptide-based drug candidates. The company's product candidates include: PTG-300, which is an injectable hepcidin mimetic for the treatment of patients with beta-thalassemia; PTF-200, which is an oral gastrointestinal (GI)-restricted Interleukin-23 receptor antagonist peptide product candidate for the treatment of inflammatory bowel disease (IBD); and PN-943, which is an oral, alpha-4-beta-7 antagonist for the treatment of IBD. The company is researching oral and injectable peptide-based product candidates for a range of conditions including hematology and GI diseases.

Pure Storage is engaged in developing data platform. The company's data platform replaces storage systems designed for mechanical disk with all-flash systems for solid-state memory. The company's Pure1 cloud-based support and management platform simplifies storage administration, while real-time scanning enables it to find and fix issues. The company's business model replaces the forklift upgrade cycle with an Evergreen Storage subscription model. The company's offerings include its FlashArray and FlashBlade products, inclusive of its Purity Operating Environment software, FlashStack and Artificial Intelligence Ready Infrastructure (AIRI), Cloud Data Services, FlashArray//X, and AIRI Mini.

Plukka is engaged in the investment in securities listed on the Australian Stock Exchange and cash.

Travelzoo provides insider deals on travel, entertainment, and lifestyle experiences across multiple digital platforms, including email, web, social media and mobile applications. The company's publications and products include the Travelzoo website (travelzoo.com), the Travelzoo iPhone and Android apps, the Travelzoo Top 20? email newsletter, and the Newsflash email alert service. The company operates the Travelzoo Network, a network of third-party websites that list deals published by Travelzoo. The Travelzoo website includes Local Deals and Getaway listings that allow its members to purchase vouchers for deals from local businesses such as spas, hotels and restaurants.